The largest database of trusted experimental protocols

13 protocols using wako cholesterol e kit

1

Quantification of Serum Cholesterol and Plasma Ang-(1-7)

Check if the same lab product or an alternative is used in the 5 most similar protocols
Serum was collected using serum separator tubes (BD Microtainers,
20,000g for 4 min). Cholesterol concentrations in sera were quantified as
described previously15 using a Wako Cholesterol E kit (Wako Diagnostics). Complete blood (20
μl) counts were quantified using MiniCollect tubes (Greiner bio-one)
followed by analysis using a Hemavet 950FS (Erba Diagnostics). Plasma (50
μl) Ang-(1-7) concentrations were quantified as described
previously13 using
a commercial ELISA (Pennisula Labs, San Carlos, CA) according to the
manufacturer’s instructions.
+ Open protocol
+ Expand
2

Amygdala Lipid Extraction and Cholesterol Quantification

Check if the same lab product or an alternative is used in the 5 most similar protocols
We used a separate group of mice that were not used in the behavioral testing to extract total lipids from amygdala-rich brain tissues. These samples were prepared with a similar method to that used for quantification of 2-AG, and cholesterol content was measured using a Wako Cholesterol E kit (Wako Pure Chemical Industry Ltd., Osaka, Japan) according to the manufacturer’s protocol.
+ Open protocol
+ Expand
3

Lipoprotein Profile Analysis in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plasma was collected from five-hour fasted mice preceding AAV injection and at 4, 8, 12, 16, and 20 weeks post-injection. Total plasma cholesterol at all time points was measured using the Wako Cholesterol E kit (999-02601). Gel filtration chromatography was completed with 220 μL pooled plasma from mice with high plasma cholesterol. Pooled plasma was loaded into a 200 μL loop on an Amersham-Pharmacia ÄKTA chromatography system equipped with two Superose HR6 columns in tandem and eluted with TBS at a flow rate of 0.5 mL/min22 (link). Lipoprotein cholesterol and triglyceride levels were determined using the Wako Cholesterol E (999-02601) and Infinity Triglycerides (TR22421) kits using 100 μL of each 1 mL fraction and expressed as micrograms per milliliter.
+ Open protocol
+ Expand
4

Cholesterol Quantification from Silica Gel

Check if the same lab product or an alternative is used in the 5 most similar protocols
The cholesterol isolated from the rhodamine 6G stained silica gel G plates was assayed using the Wako cholesterol E-Kit (Wako Chemicals, Richmond, VA, USA) according to the manufacturer’s indications.
+ Open protocol
+ Expand
5

Membrane Cholesterol Extraction and Quantification

Check if the same lab product or an alternative is used in the 5 most similar protocols
The cholesterol extraction, isolation, and quantification were achieved according to Quesada (Quesada et al. 2016 ). Briefly, the cholesterol extracted from Tc membrane and nAChR-DC were isolated from the rhodamine 6G stained silica gel G plates and further quantified using the Wako cholesterol E-Kit (Wako Chemicals, Richmond, VA, USA).
+ Open protocol
+ Expand
6

Cholesterol Measurement Protocols

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total serum cholesterol concentration and lipoprotein-cholesterol distribution were analyzed as previously described[12 (link),21 (link)]. Briefly, total serum cholesterol was measured by enzymatic colorimetric method using the Wako Cholesterol E kit (Wako Chemicals USA). Lipoprotein-cholesterol distribution was detected by size exclusion chromatography using a fast performance liquid chromatographic machine (Pharmacia LKB Biotechnology, Uppsala, Sweden).
+ Open protocol
+ Expand
7

Liver-specific Raly Knockout Mouse Model

Check if the same lab product or an alternative is used in the 5 most similar protocols
All animals used in the study were in C57BL/6 background. Our study used male mice unless otherwise specified. Mice were fed chow diet (Research Diet) and housed temperature-controlled room under a 12-h light/12-h dark cycle and pathogen-free conditions. Ralyflox/flox mice were generated by Cyagen using the strategy outlined in Fig. 1a. To the generated RALY liver-specific knockout mice and littermate controls, we treated Ralyflox/flox with adeno-associated virus (AAV) with TBG promoter (AAV8.TBG.Cre) or (AAV8.TBG.GFP; green fluorescent protein) purchased from Penn Vector Core. AAV administered intraperitoneal injection at dose of 5 × 1011 GC per mice. Mice were euthanized 4 weeks after AAV injection. Liver tissues were frozen in liquid nitrogen and stored at −80 °C or fixed in 10% formalin. Blood was collected by retro-orbital bleeding, and the plasma was separated by centrifugation. Plasma lipids were measured with the Wako L-Type TG M kit, the Wako Cholesterol E kit. All animal experiments were approved by the UCLA Institutional Animal Care and Research Advisory Committee.
+ Open protocol
+ Expand
8

OVA and PCSK9 Vaccination for Cholesterol Modulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Animals were cared for following federal, state, and local guidelines. All work performed on animals was in accordance with and approved by University Committee on Use and Care of Animals (UCUCA) at the University of Michigan, Ann Arbor. For the OVA vaccination study, female C57BL/6 mice of age 6–8 weeks (Envigo) were vaccinated 3 times in a 2-week interval by subcutaneous injection in the tail base, each with 10 μg OVA protein dose admixed with indicated adjuvants. For the PCSK9 vaccination study, female Balb/c mice of age 6–8 weeks (Envigo) were vaccinated 3 times in an 1-week interval by subcutaneous injection in the tail base with 0.5–4μg/dose (0.5μg/dose for primary vaccination and 4 μg/dose for the two booster vaccinations) of recombinant human PCSK9 (hPCSK9) admixed with indicated adjuvants containing 10μg/dose CpG and 1μg/dose MPLA. Serum cholesterol levels at indicated time points were measured using the commercially available Wako Cholesterol E kit (Wako Chemicals, Richmond, VA).
+ Open protocol
+ Expand
9

Plasma Lipid Profiling by CTAD:EDTA

Check if the same lab product or an alternative is used in the 5 most similar protocols
Baseline blood samples were collected via submandibular bleed, and post AngII infusion samples were collected via retro-orbital bleed. Blood was collected in CTAD:EDTA and centrifuged at 2000xg for 5 min to separate plasma. Total plasma cholesterol was measured with the Wako Cholesterol E Kit (Wako Diagnostics, Cat. #999-02601) and plasma triglycerides were measured using the Wako L-Type Triglyceride M kit (Wako Diagnostics, Cat. #994-02891), according to the manufacturer’s instructions.
+ Open protocol
+ Expand
10

Serum Lipoprotein Analysis by FPLC

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fast protein liquid chromatography analysis was conducted using 75 μL pooled serum from mice fasted for 16 hours (n=3 per group), separated on a Superose column (Amersham) with a flow rate of 0.4 mL/min. From each 500 μL fraction, 50 μL was used to measure total cholesterol content using the Wako Cholesterol E kit (No. 439-17501) and 16 μL was loaded for immunoblot analysis of serum lipoproteins.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!